Protein SSX4, Cancer/testis antigen 54, CT54, SSX4, SSX4A
Product description
The product of this gene belongs to the family of highly
homologous synovial sarcoma X (SSX) breakpoint proteins. These
proteins may function as transcriptional repressors. They are also
capable of eliciting spontaneously humoral and cellular immune
responses in cancer patients, and are potentially useful targets in
cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have
been involved in the t(X;18) translocation characteristically found
in all synovial sarcomas. This translocation results in the fusion
of the synovial sarcoma translocation gene on chromosome 18 to one
of the SSX genes on chromosome X. Chromosome Xp11 contains a
segmental duplication resulting in two identical copies of synovial
sarcoma, X breakpoint 4, SSX4 and SSX4B, in tail-to-tail
orientation. This gene, SSX4B, represents the more centromeric
copy. Two transcript variants encoding distinct isoforms have been
identified for this gene.1) Ayyoub, M., et al. J. Immunol. 174(8):5092-5099(2005)
Immunogen
This SSX4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 69-97 amino acids from the Central region of human SSX4.
Western blot analysis in CEM cell line lysates (35ug/lane).
Application Notes
For WB starting dilution is: 1:1000:
Additional Information
Form
Liquid
Storage Instructions
Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.